X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS JUBILANT LIFE SCIENCES DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -10.9 27.5 - View Chart
P/BV x 0.2 5.6 2.9% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs126187 67.2%   
Low Rs3165 47.5%   
Sales per share (Unadj.) Rs133.0364.3 36.5%  
Earnings per share (Unadj.) Rs0.26.8 2.2%  
Cash flow per share (Unadj.) Rs6.624.5 27.0%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %02.4 0.0%  
Book value per share (Unadj.) Rs128.8164.9 78.1%  
Shares outstanding (eoy) m31.66159.28 19.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 170.2%   
Avg P/E ratio x516.118.4 2,805.3%  
P/CF ratio (eoy) x11.85.1 230.3%  
Price / Book Value ratio x0.60.8 79.5%  
Dividend payout %043.8 0.0%   
Avg Mkt Cap Rs m2,47720,061 12.3%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m5611,052 0.5%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m4,21158,034 7.3%  
Other income Rs m79191 41.3%   
Total revenues Rs m4,28958,224 7.4%   
Gross profit Rs m5695,786 9.8%  
Depreciation Rs m2042,812 7.3%   
Interest Rs m4303,237 13.3%   
Profit before tax Rs m13-72 -17.6%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m6696 0.9%   
Profit after tax Rs m51,090 0.4%  
Gross profit margin %13.510.0 135.4%  
Effective tax rate %48.0-965.9 -5.0%   
Net profit margin %0.11.9 6.1%  
BALANCE SHEET DATA
Current assets Rs m6,85229,280 23.4%   
Current liabilities Rs m6,71138,912 17.2%   
Net working cap to sales %3.3-16.6 -20.2%  
Current ratio x1.00.8 135.7%  
Inventory Days Days16184 190.6%  
Debtors Days Days31851 628.3%  
Net fixed assets Rs m3,67355,712 6.6%   
Share capital Rs m317155 204.9%   
"Free" reserves Rs m3,76120,968 17.9%   
Net worth Rs m4,07826,265 15.5%   
Long term debt Rs m1,67117,169 9.7%   
Total assets Rs m12,63388,606 14.3%  
Interest coverage x1.01.0 105.3%   
Debt to equity ratio x0.40.7 62.7%  
Sales to assets ratio x0.30.7 50.9%   
Return on assets %3.44.9 70.5%  
Return on equity %0.14.2 2.8%  
Return on capital %7.711.6 66.3%  
Exports to sales %22.937.8 60.6%   
Imports to sales %14.316.5 86.7%   
Exports (fob) Rs m96421,933 4.4%   
Imports (cif) Rs m6029,567 6.3%   
Fx inflow Rs m96422,004 4.4%   
Fx outflow Rs m60711,749 5.2%   
Net fx Rs m35710,255 3.5%   
CASH FLOW
From Operations Rs m1,3458,026 16.8%  
From Investments Rs m-2,256-1,744 129.3%  
From Financial Activity Rs m-1,200-4,447 27.0%  
Net Cashflow Rs m-2,1111,834 -115.1%  

Share Holding

Indian Promoters % 4.5 45.6 9.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 0.0 8.7 -  
FIIs % 1.4 21.2 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.1 446.0%  
Shareholders   20,807 23,815 87.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   TORRENT PHARMA  ALKEM LABORATORIES  ELDER PHARMA  PFIZER  ALEMBIC PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS